TrialDiabetes, obesity & metabolism2025

Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trials.

Peter Rossing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.